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INTRODUCTION 
Ischemic heart disease is highly prevalent worldwide, and 
causes about one-fifth of deaths, and it is very likely to 
become the most common cause of death worldwide by 
2020.
1
 Coronary artery disease causes death, disability and 
economic loss more than any other disease in the 
developed countries and it is the most common, dangerous 
and deadly chronic disease in the United States. Over 12 
million people in US are affected by ischemic heart 
disease. Almost every minute that ticks by, coronary 
artery disease kills an American.
2
 According to statistics, 
about 15 million people out of Iran's 70-million-
population are suffering from cardiovascular diseases.
3
 As 
studies undertaken have shown, cardiovascular diseases 
are the most common cause of mortality in Iran, i.e., about 
46% of deaths occur because of it.
4
 So far, a number of 
factors including age, family history, blood fat disorders, 
high blood pressure, diabetes, history of heart disease 
have been identified effective in the development of the 
disease.
5 
The international Health Institute of America in 
2005 announced that, annually, 23 million of young 
people are diagnosed with heart disease, of which 85% 
have at least one risk factor.
6
 
Justin et al. in their study reported that 49% of heart 
patients studied had at least two risk factors.
7
 Estegamati 
et al study in Tehran showed that 30% of patients suffered 
from diabetes, 91% had hypertension, 42% were 
smoking.
8
 Diabetes mellitus is a risk factor for heart 
disease that accelerates atherosclerosis and is often 
accompanied by an increased risk of angina pectoris, 
myocardial infarction and sudden death.
1
 Fitchett asserts 
that diabetes increases the risk of heart disease up to 
ABSTRACT 
 
Background: The heart ischemic disease has become considerably prevalent worldwide and causes about one-fifth of 
deaths. Hyperlipidemia is a risk factor for atherosclerosis that includes hypercholesterolemia and hyperlipidemia.  The 
aim of this study was to study the change in the level of LDL and HDL on admission and 3months after treatment in 
patients with acute coronary syndrome (ACS).   
Methods: This is a case-series study that has been done on 180 patients with acute coronary syndrome. 24 hours after 
admission, the lipid profile was checked for patients and the amounts of LDL and HDL were registered. After drug 
prescription and three mounts later the levels of LDL and HDL were rechecked and compared. 
Results: 64.4% were men and the average age was 54.46 years. 34.44% were with diabetes, 32.7% were with high 
blood pressure, 46.6% with hyperlipidemia background, and 56.7% with smoking background. Compare the amounts 
of LDL, cholesterol and triglyceride after three months showed that the levels of them were decreased significantly. 
Conclusions: The results of this study showed that after 3 months of treatment, the mean of LDL level was more than 
the target range (70 mg/dl) that this may be due to inadequate dose of drug, irregular use, improper education to 
patient and irregular follow-up. 
  
Keywords: LDL, HDL, ACS, Hospital, Ardabil 
1
Department of Internal Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran 
2
General Practitioner, School of Medicine, Ardabil University of Medical sciences, Ardabil, Iran 
 
Received: 26 October 2015 
Accepted: 17 December 2015 
 
*Correspondence: 
Dr. Behzad Babapour, 
E-mail: b.babapour@arums.ac.ir 
 
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under 
the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial 
use, distribution, and reproduction in any medium, provided the original work is properly cited. 
DOI: http://dx.doi.org/10.18203/2349-3933.ijam20160195 
Zamani B et al. Int J Adv Med. 2016 Feb;3(1):88-91 
                                                           International Journal of Advances in Medicine | January-March 2016 | Vol 3 | Issue 1    Page 89 
almost 2 to 3 times, as such 70% of patients with diabetes 
die due to coronary artery disease.
9
 
Studies have detected a strong link between high blood 
pressure, smoking and the incidence of ischemic heart 
disease.
1,10
 
Hyperlipidemia is a risk factor for atherosclerosis which 
involves hypercholesterolemia, and hypertriglyceridemia.
1
 
Today, cholesterol, triglycerides and lipoproteins are 
examined mostly because of being tied with the major 
cause of mortality in different countries. Not only are 
abnormal concentrations of lipids and lipoproteins the 
main risk factors for cardiovascular disease, but available 
evidence suggests that changes in lipid and lipoprotein 
levels made by having food or drug interactions may also 
significantly alter the incidence of cardiovascular disease.
2
 
The purpose of this study was to examine dyslipidemia in 
patients with acute coronary syndrome, and also LDL and 
HDL levels, three months after treatment, as well as their 
success rate in the management of patients and decreasing 
their lipid level in their profile to the targeted level (less 
than 70). 
METHODS 
This is a case-series study. In this study, 180 patients with 
acute coronary syndrome, who were hospitalized in the 
cardiology ward and CCU in Ardabil Imam Hospital, 
were selected and information like age, sex, coronary risk 
factors, type and dosage of prescribed drugs when they 
were discharged from hospital, were gathered and 
recorded in the data collection sheets. The patients were 
informed about the necessity of using medication and 
were given primary instructions on keeping themselves on 
diet through educational pamphlets. Patients had visited 
the cardiology clinic one week and one month after being 
discharged from hospital and the prescribed medication 
were rechecked, and advice was given for the patients on 
regular consumption of the drugs. Eventually, in the third 
follow-up (three months after discharge) patients repeated 
examination and tests and their levels of LDL, and HDL 
were assessed again. The data, after being collected, were 
analysed in SPSS v16 using descriptive statistics, chi-
square and T-test, and were presented in the form of tables 
and charts. In all tests the level of significance was set at 
less than 0.05. 
RESULTS 
Of all patients, 116 cases (64.4%) were male and the rest 
were female. Their average age was 54.46 ± 8.66 and 65 
patients (36.1%) were in the age range between 40 and 50 
years. 62 patients (34.44%) had a history of diabetes, 59 
patients (32.7%) had hypertension, 102 patients (56.7%) 
were smokers, and 100 patients (55.6%) had taken 
medications irregularly. 84 cases (46.6%) had 
hyperlipidemia. 
At the beginning of study, the LDL level of 113 patients 
(86.7%) was more the targeted level. After 3 months, this 
number reduced to 38 patients (21.1%). Additionally, it 
was also observed that average LDL level in patients went 
down significantly, after three months of treatment (P = 
0.001) (Table 1). 
The assessment of HDL level, three months following 
treatment, showed no significant increase in HDL level of 
patients (Table 1). 
The number of patients who had high total cholesterol 
level (i.e., 127 patients, 70.6%) fell to 58 patients (32.2%) 
by the end of the third month. It was also observed that 
three months after treatment, total cholesterol levels 
reduced significantly (P = 0.001) (Table 1). 
In the beginning of the study, the number of patients with 
an increased level of triglyceride was 159 (88.33%). This 
number decreased to 41 patients (22.77%), following 3 
months of treatment. The results showed that the decrease 
in triglyceride level of the patients after three months of 
treatment was significant (P = 0.033) (Table 1). 
Table 1: The mean of LDL, HDL, TG and Cholesterol 
during study. 
Variables Time Mean±SD P-Value 
LDL On Admission  220.1±22.6 0.001 
Three month late 87.9±18.4 
HDL On Admission  39.5±11.9 0.134 
Three month late 37.9±8.4 
TG On Admission  197.7±40.2 0.001 
Three month late 164.9±25.5 
Cholesterol On Admission  218.3±158.9 0.033 
Three month late 186.2±124.4 
DISCUSSION 
Of the patients, 64.4 percent were male and the average 
age of the patients was 54.5 years, which was similar to 
the studies done in other places in terms of age and 
sex.
4,11-13
 Considering LDL, it was observed that 86.7%, 
and 21.1% of patient were of abnormal level of LDL at 
the beginning and at the end of the study, respectively, 
indicating that treatment significantly reduced LDL levels 
(P <0.001). Similarly, at the beginning of and at the end of 
the study, 70.6% and 32.2% of patients, respectively had 
increased cholesterol level, that treatment could 
significantly reduce (P<0.001). Additionally, 88.3% of 
patients at the beginning of the study and 22.8% percent at 
the end of the study had increased level of triglyceride, 
that treatment also had a significant effect on its drop (P = 
0.033). However, no significant change was observed in 
HDL levels. Asadpour et al in their study found that 
62.8% of patients with final diagnosis for acute coronary 
syndrome, had dyslipidemia.
4
 In a study conducted by 
Heydari et al two groups of patients with coronary heart 
disease  (n = 386), and without coronary heart disease 
(181 patients) were compared and  no significant 
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difference was detected  in total cholesterol and LDL-C 
between groups, while their difference in triglyceride and 
HDL-C levels was significant.
10
 In a study by Sakuma et 
al, low HDL-C in men, and high triglyceride and low 
HDL-C and in women, were the main risk factors for 
acute coronary syndrome.
11
 In the study done by 
Hammoudeh et al, the prevalence rate of 
hypercholesterolemia and hypertriglyceridemia was 19% 
and 27% respectively.
12
 The prevalence of low HDL-C in 
men and women with coronary heart disease was more 
common than in men and women without coronary heart 
disease, but the prevalence of hypercholesterolemia and 
hypertriglyceridemia didn't vary across two groups. In 
their study, Radovanovic et al
 
observed that of all the 
patients with acute coronary syndrome, 45% had 
dyslipidemia.
14
 Additionally they found that early 
administration of lipid-lowering medication was 
associated with lower in-hospital mortality. Rosenson et 
al. identified atorvastatin and rosuvastatin as the most 
effective drugs in reducing serum LDL, while atorvastatin 
and rosuvastatin are also equally effective in reducing 
triglycerides and are the best medication for lowering it in 
serum.
15-17
 Considering the above study's finding and 
comparing it with other studies, the lack of appropriate 
reduction in LDL cholesterol can be attributed to several 
factors mentioned below:  
1. The low doses of drugs like atorvastatin that in this 
study the majority of patients were taking the dose of 
20 mg/dl. 
2. Irregular drug use, more than half of patients had 
taken the drug irregularly in this study. 
3. Lack of follow-up and lack of timely visit or referring 
to other doctors, different drug prescriptions may 
have led to change in the dosage of drug and have 
controlled the patients' lipid profiles. 
4. Patients not having timely routine tests which can be 
attributed to their unawareness of the necessity of 
follow-up tests.   
CONCLUSIONS 
The results showed that the mean level of LDL after three 
months was more than the target amount (more than 70 
mg/dl), which can be due to inadequate drug dosage, 
irregular use of medication, inadequate training or 
irregular follow-up which needs to be reviewed. 
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